Genibone-D3 Softgel Capsule contains Vitamin D3 (Cholecalciferol) at a strength of 60,000 IU per capsule, designed to address and prevent Vitamin D deficiency in adults. Vitamin D3 plays a crucial role in calcium and phosphorus homeostasis, promoting optimal bone mineralization and maintaining skeletal health. This high-potency formulation is indicated for the treatment of Vitamin D deficiency states, including osteomalacia, rickets, and certain cases of hypoparathyroidism. It may also be used as adjunct therapy in osteoporosis management and in conditions associated with impaired calcium absorption. Genibone-D3 enhances intestinal absorption of calcium, thereby supporting bone density and reducing the risk of fractures. The softgel capsule form ensures improved bioavailability and ease of administration. Dosage should be individualized based on serum 25-hydroxyvitamin D levels and clinical response, with monitoring recommended to avoid hypervitaminosis D and hypercalcemia. Contraindications include hypercalcemia, hypervitaminosis D, and hypersensitivity to any component of the formulation. Caution is advised in patients with renal impairment or granulomatous diseases. Adverse effects are rare but may include gastrointestinal discomfort, hypercalcemia symptoms, and allergic reactions. Genibone-D3 Softgel Capsule should be used under medical supervision to ensure safe and effective correction of Vitamin D deficiency.